Key Themes & Topics
Novel Formulation Strategies for Complex Biologics - mAbs, Bispecifics, & ADCs
Adjuvants & Immunostimulatory Technologies - Amplifying Vaccine Potency
Formulation Supply Chain – From Clinical to Commercial
LNP & RNA Formulation
From Formulation to Device Integration
Smart Aseptic Fill–Finish
John Bridgeman | CSO, Immunokey, UK
"Thanks for the invite to speak at the event. It was a really enjoyable meeting and a great opportunity to present our work to the community. Identifying key partners for ImmunoKey’s development plan is a critical aspect of getting our therapies to patients; the CGT and Biologics Manufacturing DACH meeting offered us the opportunity to engage with key CDMOs who can help us achieve this goal."
Terry Gray | Field Marketing Manager, Merck
"I had the pleasure of collaborating with the IMAPAC team during the Irish leg of the Biologics World event in February 2026. The organisers were exceptionally receptive and helpful, ensuring a seamless experience throughout the planning, exhibition logistics, partnering sessions, and sponsor visibility. Their proactive approach in connecting us with potential partners significantly enhanced our ROI. We are already exploring future opportunities to work with the IMAPAC team."
WHO
For biopharma biotech and pharmaceutical leaders across Europe working in RNA design vaccine R&D biologics formulation drug delivery and stability science. This includes R&D Drug Product Analytical Development, CMC, Quality, Manufacturing professionals from leading pharmaceutical companies innovative biotechs, CDMOs, technology providers, and academic & research institutions.
WHAT
A strategic platform dedicated to advancing the next generation of biologics formulation, stability, and delivery. BioFormulate Live 2026 unites three concurrent scientific streams - RNA Therapeutics, Vaccine Innovation, and Biologics Formulation & Delivery, offering deep technical insights spanning early development through to commercial-scale production.
WHY
To accelerate innovation in biologics drug development by bringing together top scientific, technical, and regulatory experts. Attendees gain practical solutions to stability challenges, formulation optimisation, patient-focused delivery, and manufacturing scale-up. The event enables high-value collaboration, technology discovery, and future-focused insights at the junction where formulation science meets global healthcare impact.
Senior Attendees
Meet a concentrated audience of biologics RNA and vaccine development leaders from global pharma biotechs CDMOs and academia.
Expert Speakers
Hear from world class leaders in RNA engineering formulation science structural biology vaccine innovation and drug product development.
Companies Represented
A pan European gathering representing biopharma technology providers regulatory bodies and academic institutions.
